Annual Operating Expenses
$13.58 M
-$7.68 M-36.13%
31 December 2023
Summary:
GT Biopharma annual total operating expenses is currently $13.58 million, with the most recent change of -$7.68 million (-36.13%) on 31 December 2023. During the last 3 years, it has risen by +$6.81 million (+100.71%). GTBP annual operating expenses is now -89.99% below its all-time high of $135.57 million, reached on 31 December 2017.GTBP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.60 M
-$302.00 K-7.73%
30 September 2024
Summary:
GT Biopharma quarterly total operating expenses is currently $3.60 million, with the most recent change of -$302.00 thousand (-7.73%) on 30 September 2024. Over the past year, it has increased by +$482.00 thousand (+15.44%). GTBP quarterly operating expenses is now -97.16% below its all-time high of $126.86 million, reached on 30 September 2017.GTBP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.1% | +15.4% |
| 3 y3 years | +100.7% | -39.5% |
| 5 y5 years | -37.0% | -15.3% |
GTBP Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -76.4% | +100.7% | -80.2% | +19.6% |
| 5 y | 5 years | -76.4% | +100.7% | -87.6% | +316.2% |
| alltime | all time | -90.0% | +1352.0% | -97.2% | +2620.3% |
GT Biopharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.60 M(-7.7%) |
| June 2024 | - | $3.91 M(+26.4%) |
| Mar 2024 | - | $3.09 M(-2.4%) |
| Dec 2023 | $13.58 M(-36.1%) | $3.17 M(+1.5%) |
| Sept 2023 | - | $3.12 M(-13.8%) |
| June 2023 | - | $3.62 M(-1.2%) |
| Mar 2023 | - | $3.67 M(-36.6%) |
| Dec 2022 | $21.26 M(-63.0%) | $5.78 M(-17.7%) |
| Sept 2022 | - | $7.02 M(+133.0%) |
| June 2022 | - | $3.01 M(-44.6%) |
| Mar 2022 | - | $5.44 M(-70.1%) |
| Dec 2021 | $57.52 M(+750.3%) | $18.18 M(+205.3%) |
| Sept 2021 | - | $5.95 M(+35.9%) |
| June 2021 | - | $4.38 M(-84.9%) |
| Mar 2021 | - | $29.00 M(+1223.7%) |
| Dec 2020 | $6.76 M(-41.0%) | $2.19 M(+12.6%) |
| Sept 2020 | - | $1.95 M(+24.8%) |
| June 2020 | - | $1.56 M(+45.6%) |
| Mar 2020 | - | $1.07 M(+23.6%) |
| Dec 2019 | $11.46 M(-46.8%) | $866.00 K(-79.7%) |
| Sept 2019 | - | $4.26 M(+86.7%) |
| June 2019 | - | $2.28 M(-43.8%) |
| Mar 2019 | - | $4.06 M(+31.2%) |
| Dec 2018 | $21.55 M(-84.1%) | $3.09 M(-49.7%) |
| Sept 2018 | - | $6.15 M(+19.2%) |
| June 2018 | - | $5.16 M(-28.0%) |
| Mar 2018 | - | $7.16 M(+21.5%) |
| Dec 2017 | $135.57 M(+1346.2%) | $5.89 M(-95.4%) |
| Sept 2017 | - | $126.86 M(+9772.1%) |
| June 2017 | - | $1.28 M(-16.4%) |
| Mar 2017 | - | $1.54 M(+87.1%) |
| Dec 2016 | $9.37 M(+4.7%) | $822.00 K(-67.5%) |
| Sept 2016 | - | $2.53 M(+19.3%) |
| June 2016 | - | $2.12 M(-45.6%) |
| Mar 2016 | - | $3.90 M(+34.1%) |
| Dec 2015 | $8.95 M(+273.1%) | $2.91 M(+4.7%) |
| Sept 2015 | - | $2.78 M(+91.4%) |
| June 2015 | - | $1.45 M(-20.2%) |
| Mar 2015 | - | $1.82 M(+10.9%) |
| Dec 2014 | $2.40 M(+156.7%) | $1.64 M(+199.8%) |
| Sept 2014 | - | $547.00 K(+388.4%) |
| June 2014 | - | $112.00 K(+10.9%) |
| Mar 2014 | - | $101.00 K(-59.8%) |
| Dec 2013 | $935.00 K(-75.1%) | $251.00 K(+25.5%) |
| Sept 2013 | - | $200.00 K(+69.5%) |
| June 2013 | - | $118.00 K(-67.8%) |
| Mar 2013 | - | $366.00 K(-59.2%) |
| Dec 2012 | $3.76 M(-3.7%) | $897.00 K(-37.6%) |
| Sept 2012 | - | $1.44 M(+39.5%) |
| June 2012 | - | $1.03 M(+159.7%) |
| Mar 2012 | - | $397.00 K(-62.2%) |
| Dec 2011 | $3.91 M(+59.9%) | $1.05 M(+96.4%) |
| Sept 2011 | - | $535.00 K(+14.6%) |
| June 2011 | - | $467.00 K(-74.8%) |
| Mar 2011 | - | $1.85 M(+291.8%) |
| Dec 2010 | $2.44 M(+111.7%) | $473.00 K(-27.7%) |
| Sept 2010 | - | $654.00 K(+69.4%) |
| June 2010 | - | $386.00 K(-58.5%) |
| Mar 2010 | - | $930.00 K(+32.7%) |
| Dec 2009 | $1.15 M(-20.1%) | $701.00 K(+734.5%) |
| Sept 2009 | - | $84.00 K(-63.6%) |
| June 2009 | - | $231.00 K(+66.2%) |
| Mar 2009 | - | $139.00 K(-54.0%) |
| Dec 2008 | $1.45 M(-63.0%) | $302.00 K(-13.5%) |
| Sept 2008 | - | $349.00 K(+96.1%) |
| June 2008 | - | $178.00 K(-71.1%) |
| Mar 2008 | - | $615.00 K(-46.3%) |
| Dec 2007 | $3.90 M | $1.15 M(+13.4%) |
| Sept 2007 | - | $1.01 M(+59.1%) |
| June 2007 | - | $635.00 K(-43.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | - | $1.11 M(-41.7%) |
| Dec 2006 | $5.36 M(+88.7%) | $1.91 M(+64.7%) |
| Sept 2006 | - | $1.16 M(+14.3%) |
| June 2006 | - | $1.01 M(-20.5%) |
| Mar 2006 | - | $1.28 M(+16.2%) |
| Dec 2005 | $2.84 M(+23.3%) | $1.10 M(+103.9%) |
| Sept 2005 | - | $539.00 K(-10.9%) |
| June 2005 | - | $605.00 K(+1.2%) |
| Mar 2005 | - | $598.00 K(-518.2%) |
| Dec 2004 | $2.30 M(+14.2%) | -$143.00 K(-127.1%) |
| Sept 2004 | - | $528.00 K(-24.4%) |
| June 2004 | - | $698.00 K(+0.3%) |
| Mar 2004 | - | $696.00 K(+13.9%) |
| Dec 2003 | $2.02 M(+17.2%) | $611.00 K(+37.3%) |
| Sept 2003 | - | $445.00 K(-6.9%) |
| June 2003 | - | $478.00 K(-1.0%) |
| Mar 2003 | - | $483.00 K(+37.2%) |
| Dec 2002 | $1.72 M(-56.9%) | $352.00 K(-26.8%) |
| Sept 2002 | - | $481.00 K(+14.3%) |
| June 2002 | - | $421.00 K(-9.9%) |
| Mar 2002 | - | $467.00 K(-63.5%) |
| Dec 2001 | $3.99 M(-29.4%) | $1.28 M(+163.0%) |
| Sept 2001 | - | $487.00 K(-63.7%) |
| June 2001 | - | $1.34 M(-0.8%) |
| Mar 2001 | - | $1.35 M(-15.8%) |
| Dec 2000 | $5.65 M(-13.4%) | $1.61 M(-0.7%) |
| Sept 2000 | - | $1.62 M(+33.8%) |
| June 2000 | - | $1.21 M(-0.6%) |
| Mar 2000 | - | $1.22 M(-8.2%) |
| Dec 1999 | $6.52 M(-32.0%) | $1.32 M(+10.3%) |
| Sept 1999 | - | $1.20 M(-42.9%) |
| June 1999 | - | $2.10 M(+5.0%) |
| Mar 1999 | - | $2.00 M(-31.0%) |
| Dec 1998 | $9.60 M(+18.5%) | $2.90 M(+7.4%) |
| Sept 1998 | - | $2.70 M(+42.1%) |
| June 1998 | - | $1.90 M(-17.4%) |
| Mar 1998 | - | $2.30 M(+15.0%) |
| Dec 1997 | $8.10 M(-11.0%) | $2.00 M(-4.8%) |
| Sept 1997 | - | $2.10 M(+16.7%) |
| June 1997 | - | $1.80 M(-18.2%) |
| Mar 1997 | - | $2.20 M(-4.3%) |
| Dec 1996 | $9.10 M(+1.1%) | $2.30 M(+4.5%) |
| Sept 1996 | - | $2.20 M(-8.3%) |
| June 1996 | - | $2.40 M(+4.3%) |
| Mar 1996 | - | $2.30 M(-14.8%) |
| Dec 1995 | $9.00 M(+125.0%) | $2.70 M(+28.6%) |
| Sept 1995 | - | $2.10 M(0.0%) |
| June 1995 | - | $2.10 M(0.0%) |
| Mar 1995 | - | $2.10 M(-4.5%) |
| Dec 1994 | $4.00 M(+14.3%) | $2.20 M(+144.4%) |
| Sept 1994 | - | $900.00 K(+125.0%) |
| June 1994 | - | $400.00 K(-20.0%) |
| Mar 1994 | - | $500.00 K(-28.6%) |
| Dec 1993 | $3.50 M(+66.7%) | $700.00 K(-22.2%) |
| Sept 1993 | - | $900.00 K(-40.0%) |
| June 1993 | - | $1.50 M(+275.0%) |
| Mar 1993 | - | $400.00 K(0.0%) |
| Dec 1992 | $2.10 M(-4.5%) | $400.00 K(-33.3%) |
| Sept 1992 | - | $600.00 K(+20.0%) |
| June 1992 | - | $500.00 K(0.0%) |
| Mar 1992 | - | $500.00 K(0.0%) |
| Dec 1991 | $2.20 M(-8.3%) | $500.00 K(-16.7%) |
| Sept 1991 | - | $600.00 K |
| Dec 1990 | $2.40 M(-4.0%) | - |
| Dec 1989 | $2.50 M(+19.0%) | - |
| Dec 1988 | $2.10 M(+31.3%) | - |
| Dec 1987 | $1.60 M(-36.0%) | - |
| Dec 1986 | $2.50 M(+8.7%) | - |
| Dec 1985 | $2.30 M(+9.5%) | - |
| Dec 1984 | $2.10 M(+10.5%) | - |
| Feb 1984 | $1.90 M | - |
FAQ
- What is GT Biopharma annual total operating expenses?
- What is the all time high annual operating expenses for GT Biopharma?
- What is GT Biopharma annual operating expenses year-on-year change?
- What is GT Biopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for GT Biopharma?
- What is GT Biopharma quarterly operating expenses year-on-year change?
What is GT Biopharma annual total operating expenses?
The current annual operating expenses of GTBP is $13.58 M
What is the all time high annual operating expenses for GT Biopharma?
GT Biopharma all-time high annual total operating expenses is $135.57 M
What is GT Biopharma annual operating expenses year-on-year change?
Over the past year, GTBP annual total operating expenses has changed by -$7.68 M (-36.13%)
What is GT Biopharma quarterly total operating expenses?
The current quarterly operating expenses of GTBP is $3.60 M
What is the all time high quarterly operating expenses for GT Biopharma?
GT Biopharma all-time high quarterly total operating expenses is $126.86 M
What is GT Biopharma quarterly operating expenses year-on-year change?
Over the past year, GTBP quarterly total operating expenses has changed by +$482.00 K (+15.44%)